(3)
The
property-specific risk assessment is comprised of four parts: selection of
chemicals of concern, exposure assessment, toxicity assessment, and
characterization of risk. These four parts are as follows:
(a)
Selection of
COCs. Hazardous substances or petroleum identified on or from the property are
considered COCs and the volunteer shall evaluate such COCs pursuant to all the
appropriate risk assessment calculations and methods referenced in paragraph
(D)(3) of this rule if such hazardous substances or petroleum fall into one of
the following categories:
(i)
Do not meet the applicable standards established for
background pursuant to paragraph (H) of rule
3745-300-07
of the Administrative Code.
(ii)
Do not
constitute contamination in de minimis or previously addressed areas pursuant
to paragraph (E) of rule
3745-300-06
of the Administrative Code.
(iii)
Cannot be
removed from the list of COCs pursuant to paragraph (F) (5)(f) of rule
3745-300-07
of the Administrative Code.
(b)
Exposure
assessment. The exposure assessment shall determine the reasonably anticipated
magnitude, frequency, duration, and routes of exposure. The exposure assessment
shall include consideration of the information obtained or activities performed
under paragraph (D)(2) of this rule for the known and reasonably anticipated
land use.
(i)
Identification of receptor populations. The exposure
assessment shall evaluate the risk and hazard potential to all receptor
populations as identified in paragraph (E)(6) of rule
3745-300-07
of the Administrative Code that are reasonably anticipated to be exposed to
COCs on or from the property. The exposure assessment shall evaluate
populations for the magnitude and frequency of exposure for each exposure
period.
(ii)
Evaluation of exposure pathways, as follows:
(a)
The
property-specific exposure assessment shall evaluate all complete exposure
pathways in accordance with paragraph (F)(1) of rule
3745-300-07
of the Administrative Code.
(b)
The exposure
assessment shall include a written justification for all exposure pathways
eliminated or mitigated through the use of institutional controls or
engineering controls. The written justification shall include a description of
the efficacy of such controls. The volunteer shall implement the described
institutional controls or engineering controls in accordance with rules
3745-300-11 and
3745-300-13
of the Administrative Code.
(c)
The volunteer
shall evaluate complete exposure pathways in accordance with the procedures in
the following sources, as incorporated by reference in rule
3745-300-15
of the Administrative Code:
(i)
U.S. EPA's "Risk Assessment Guidance for Superfund
(RAGs), Volume I: Human Health Evaluation Manual (Part A)."
(ii)
U.S. EPA's "Risk
Assessment Guidance for Superfund (RAGs), Volume I: Human Health Evaluation
Manual (Part E, Supplemental Guidance for Dermal Risk
Assessment."
(iii)
U.S. EPA's "Risk Assessment Guidance for Superfund
(RAGs), Volume I: Human Health Evaluation Manual (Part F, Supplemental Guidance
for Inhalation Risk Assessment)."
(iv)
U.S. EPA's
"Exposure Factors Handbook," 2011 Edition and 2017 Chapter 5
updates.
(v)
U.S. EPA's "Human Health Evaluation Manual,
Supplemental Guidance: Standard Default Exposure Factors."
(iii)
Quantification of chemical-specific intake. The
volunteer shall calculate chemical-specific intakes to quantify the exposure of
each receptor population as identified in accordance with paragraph (E) (6) of
rule
3745-300-07
of the Administrative Code, to COCs on or from the property as identified in
accordance with paragraph (D) (3)(a) of this rule, and for each medium
identified in a phase II property assessment.
(a)
The volunteer
shall calculate the chemical-specific intakes using formulas identified in the
following sources, as incorporated by reference in rule
3745-300-15
of the Administrative Code:
(i)
U.S. EPA's "Risk Assessment Guidance for Superfund
(RAGs), Volume I: Human Health Evaluation Manual (Part A)."
(ii)
U.S. EPA's "Risk
Assessment Guidance for Superfund (RAGs), Volume I: Human Health Evaluation
Manual (Part E, Supplemental Guidance for Dermal Risk
Assessment."
(iii)
U.S. EPA's "Risk Assessment Guidance for Superfund
(RAGs), Volume I: Human Health Evaluation Manual (Part F, Supplemental Guidance
for Inhalation Risk Assessment)."
(iv)
U.S. EPA's
"Exposure Factors Handbook," 2011 Edition and 2017 Chapter 5
updates.
(v)
U.S. EPA's "Human Health Evaluation Manual,
Supplemental Guidance: Standard Default Exposure Factors."
(vi)
Ohio EPA's
"Support Document for the Development of Generic Numerical Standards and Risk
Assessment Procedures."
(b)
The volunteer
shall determine the numerical values for the exposure factor terms in formulas
in accordance with paragraphs (D)(3)(b)(iii)(c) and (D)(3)(b)(iii)(d) of this
rule.
(c)
Exposure factors.
(i)
The volunteer
shall determine the exposure factor values either as point values or as the
output value from a probabilistic simulation of twenty thousand or more
iterations which solve for the chemical-specific intake equation. A
probabilistic simulation output value for the intake shall be the ninetieth per
centile or greater value.
(ii)
For risk-derived
unrestricted potable use ground water, the volunteer shall obtain exposure
factor values using the reasonable maximum exposure point values in Ohio EPA's
"Support Document for the Development of Generic Numerical Standards and Risk
Assessment Procedures," which are the basis for the development of the generic
unrestricted potable use standards listed in appendix A to rule
3745-300-08
of the Administrative Code. Distributions developed by the volunteer shall
adequately describe the parameter in question following U.S. EPA's "Risk
Assessment Guidance for Superfund (RAGs), Volume I: Human Health Evaluation
Manual (Part A)."
(iii)
For all other pathways, the volunteer shall obtain the
exposure factor values using one of the following methods:
(A)
Exposure factor
values not determined from property-specific information. For exposure factors
represented by a point value, these values shall be upper bound or central
tendency with an estimate of upper-bound exposures obtained in accordance with
U.S. EPA's "Human Health Evaluation Manual, Supplemental Guidance: Standard
Default Exposure Factors" and Ohio EPA's "Support Document for the Development
of Generic Numerical Standards and Risk Assessment Procedures" for the complete
exposure pathway which contributes most substantially to risk, and for any
other complete exposure pathways for which upper-bound exposures are deemed
likely. For all other complete exposure pathways, exposure factor point values
shall be the values representative of central tendency, upper bound or other
appropriate exposures as defined in Ohio EPA's "Support Document for the
Development of Generic Numerical Standards and Risk Assessment Procedures."
When exposure factor values are represented by probability distributions as
input for a probabilistic simulation, the volunteer shall derive the
probability distributions using guidance in U.S. EPA's "Risk Assessment
Guidance for Superfund (RAGs), Volume III Part A: Process for Conducting a
Probabilistic Risk Assessment."
(B)
Exposure factor
values determined from property-specific information. For the complete exposure
pathway which contributes most substantially to risk, and for any other
complete exposure pathways for which upper-bound exposures are deemed likely,
the property-specific exposure factor value shall reasonably represent the
upper bound value or central tendency value from a distribution of
property-specific data, as appropriate. Exposure factor values shall be
consistent with an estimate of upper-bound exposures as described in U.S. EPA's
"Risk Assessment Guidance for Superfund (RAGs), Volume I: Human Health
Evaluation Manual (Part A)," and Ohio EPA's "Support Document for the
Development of Generic Numerical Standards and Risk Assessment Procedures." For
all other complete exposure pathways, the property-specific exposure factor
values shall reasonably represent either an upper-bound or central tendency
value from a distribution of property-specific data for that exposure factor
term. Property-specific exposure factor distributions and, if used, the upper
bound or central tendency values derived from property-specific exposure factor
distributions, shall meet the criteria for property-specific data described in
paragraph (D)(3)(b)(iv) of this rule.
(d)
Exposure point
concentration. The volunteer shall determine exposure point concentrations for
each complete exposure pathway and shall represent the concentration of COCs
from each of the identified areas or exposure units. This representation of
exposure point concentration shall be consistent with concentrations of the
COCs determined in accordance with paragraph (F)(6) of rule
3745-300-07
of the Administrative Code, and the exposure factor values as determined in
accordance with paragraph (D)(3)(b)(iii)(c) of this rule.
(iv)
Criteria for use of property-specific data.
Property-specific data used in the identification of receptor populations
described in paragraph (D)(3)(b)(i) of this rule, the identification of
exposure pathways as described in paragraph (D)(3)(b)(ii) of this rule, or the
quantification of chemical-specific intake as described in paragraph
(D)(3)(b)(iii) of this rule, shall meet the following criteria:
(a)
The volunteer
shall collect property-specific physical data in accordance with paragraph (E)
of rule
3745-300-07
of the Administrative Code.
(b)
Property-specific information used to define any parameter which requires the
prediction of human use and activity patterns on a property, or the physical,
physiological, and behavioral characteristics of the receptor populations shall
be representative of the reasonably anticipated land use category and the
actual property characteristics, and shall be included in an institutional
control or engineering control that complies with rule
3745-300-11 of the
Administrative Code.
(c)
Peer-reviewed literature sources may be used for the
express intent to define property-specific data for paragraphs (D)(3)(b)(i),
(D)(3)(b)(ii), and (D)(3)(b)(iii) of this rule. Literature-based data shall be
consistent with property-specific conditions.
(c)
Toxicity
assessment.
(i)
Information hierarchy. The volunteer shall obtain the
toxicity information used in a property-specific risk assessment from the
following hierarchy:
(a)
U.S. EPA toxicity values [i.e., "Integrated Risk
Information System" (IRIS)]. The volunteer shall obtain the most current
toxicity information from the IRIS for COCs that are being evaluated in the
property-specific risk assessment.
(b)
Ohio EPA toxicity
information. If the toxicity information required to be used in a
property-specific risk assessment is not in the IRIS, or is not listed in Ohio
EPA's "Support Document for the Development of Generic Numerical Standards and
Risk Assessment Procedures," the volunteer shall consult Ohio EPA to obtain
appropriate toxicity information.
(ii)
Absorption
factors and adjustment of toxicity values, as follows:
(i)
Information
hierarchy. The volunteer shall obtain the toxicity information used in a
property-specific risk assessment from the following hierarchy:
(a)
U.S. EPA toxicity
values [i.e., "Integrated Risk Information System" (IRIS)]. The volunteer shall
obtain the most current toxicity information from the IRIS for COCs that are
being evaluated in the property-specific risk assessment.
(b)
Ohio EPA toxicity
information. If the toxicity information required to be used in a
property-specific risk assessment is not in the IRIS, or is not listed in Ohio
EPA's "Support Document for the Development of Generic Numerical Standards and
Risk Assessment Procedures," the volunteer shall consult Ohio EPA to obtain
appropriate toxicity information.
(ii)
Absorption
factors and adjustment of toxicity values, as follows:
(a)
The volunteer
shall evaluate the toxicity values selected for use in the property-specific
risk assessment as described in paragraph (D)(3)(c)(i) of this rule for each of
the COCs in conjunction with the quantification of chemical-specific intake as
described in paragraph (D)(3)(b)(iii) of this rule for each complete exposure
pathway, in accordance with the procedures described in U.S. EPA's "Risk
Assessment Guidance for Superfund (RAGs), Volume I: Human Health Evaluation
Manual (Part A)," and U.S. EPA's "Risk Assessment Guidance for Superfund
(RAGs), Volume I: Human Health Evaluation Manual (Part E, Supplemental Guidance
for Dermal Risk Assessment)."
(b)
The volunteer
shall perform the risk characterization in accordance with the procedures
described in paragraph (D) (3)(d) of this rule so that chemical-specific intake
and toxicity values are both expressed as the absorbed dose or both expressed
as the administered dose.
(c)
The volunteer shall obtain default and
chemical-specific absorption factor and bioavailability values in accordance
with U.S. EPA's "Risk Assessment Guidance for Superfund (RAGs), Volume I: Human
Health Evaluation Manual (Part A)," and U.S. EPA's "Risk Assessment Guidance
for Superfund (RAGs), Volume I: Human Health Evaluation Manual (Part E,
Supplemental Guidance for Dermal Risk Assessment)" or from Ohio EPA's "Support
Document for the Development of Generic Numerical Standards and Risk Assessment
Procedures."
(d)
Risk characterization. Risk characterization shall
integrate the exposure and toxicity assessments in order to quantitatively
determine the risk or hazard posed by the COCs on or from the property. The
risk characterization shall evaluate carcinogenic risks and non-carcinogenic
hazard separately.
(i)
Cancer risk
characterization. The volunteer shall estimate cancer risks as an incremental
probability of an individual member of a receptor population developing cancer
over a lifetime as a result of exposure to carcinogenic COCs on or from the
property; hereafter, this estimation of cancer risk is referred to as
incremental cancer risk. The volunteer shall calculate separately an
incremental cancer risk, at a minimum, for each receptor population identified
in accordance with the procedures described in paragraph (D)(3)(b)(i) of this
rule. An estimate of incremental cancer risk for each receptor population shall
not exceed the applicable carcinogenic risk goal in paragraph (B)(1) of this
rule. An estimate of incremental cancer risk is calculated as follows:
(a)
A volunteer shall
determine incremental cancer risk in accordance with the procedures described
in this rule and in U.S. EPA's "Risk Assessment Guidance for Superfund (RAGs),
Volume I: Human Health Evaluation Manual (Part A)" for each carcinogenic COC
and for each complete exposure pathway identified in accordance with paragraphs
(D)(3)(a) and (D)(3)(b)(ii) of this rule, respectively.
(b)
If incremental
cancer risk is determined for a receptor population for more than one
carcinogenic COC, the volunteer shall calculate separately, as appropriate, the
cumulative incremental cancer risk posed by these multiple COCs, for each
complete exposure pathway in accordance with the procedures described in U.S.
EPA's "Risk Assessment Guidance for Superfund (RAGs), Volume I: Human Health
Evaluation Manual (Part A)."
(c)
If incremental
cancer risk is determined for a receptor population for more than one complete
exposure pathway, the volunteer shall calculate the cumulative incremental
cancer risk posed by an estimate based on the complete exposure pathways in
accordance with the procedures described in paragraph (D)(3)(d) of this rule
and in U.S. EPA's "Risk Assessment Guidance for Superfund (RAGs), Volume I:
Human Health Evaluation Manual (Part A)."
(ii)
Noncancer hazard
characterization. The volunteer shall calculate a hazard index value to
determine the exposure which is not likely to cause noncancer adverse health
effects posed by COCs to each receptor population at a property for the
duration of that exposure in accordance with the applicable noncancer hazard
goals described in paragraph (B)(2) of this rule. The volunteer shall calculate
a separate hazard index for each receptor population over a specified exposure
period (i.e., chronic or sub-chronic exposure) identified in accordance with
the procedures described in paragraph (D)(3)(b) (ii) of this rule, as
follows:
(a)
The volunteer shall calculate a hazard quotient for each COC with noncancer
effects described by a reference dose or reference concentration for each
complete exposure pathway in accordance with the procedures described in this
rule and in U.S. EPA's "Risk Assessment Guidance for Superfund (RAGs), Volume
I: Human Health Evaluation Manual (Part A)."
(b)
If the volunteer
determines hazard quotient values representing noncancer hazards for one
receptor population over a specified exposure period for more than one COC as
described in paragraph (D)(3)(d)(ii)(a) of this rule, the volunteer shall
calculate separately, as appropriate, the cumulative noncancer hazards posed by
these COCs as a hazard index value for each complete exposure pathway in
accordance with the procedures described in U.S. EPA's "Risk Assessment
Guidance for Superfund (RAGs), Volume I: Human Health Evaluation Manual (Part
A)." The volunteer may perform separate hazard index calculations based on the
consideration of major non-carcinogenic toxic endpoints, which shall include,
at a minimum, those toxic endpoints identified with the critical effect upon
which the reference dose or reference concentration is based, for each
non-carcinogenic COC. The volunteer shall submit a written justification for
separate hazard index calculations in the property-specific risk assessment
report.
(c)
If the volunteer determines hazard index values
representing noncancer hazard for one receptor population over a specified
exposure period for more than one complete exposure pathway, the volunteer
shall calculate cumulative noncancer hazard posed by one or more complete
exposure pathways, as appropriate, as a hazard index value in accordance with
the procedures described in this rule and in U.S. EPA's "Risk Assessment
Guidance for Superfund (RAGs), Volume I: Human Health Evaluation Manual (Part
A)." Exclusion of one or more non-carcinogenic COCs from the hazard index
calculations performed in accordance with paragraph (D)(3) (d)(ii)(b) of this
rule may be reconsidered with respect to the toxic endpoints, (including, as
available, target organ, modes of action, or mechanisms of action) identified
for the non-carcinogenic COCs associated with each complete exposure pathway
considered in accordance with this paragraph.
(iii)
Uncertainty
analysis. The volunteer shall evaluate uncertainty associated with the
property-specific risk assessment. The uncertainty analysis shall include a
qualitative description or quantitative evaluation of uncertainty associated
with any of the following:
(a)
Selection of COCs and the exposure point
concentration.
(b)
Estimates of chemical-specific intake
factors.
(c)
Complete exposure pathways.
(d)
Toxicity
criteria.
(e)
Additive or antagonistic effects of exposure to
multiple COCs through one or more complete exposure pathways.
(f)
Evaluation of
site-specific, epidemiological, or health studies.